Officials access non-public information (upcoming legislation, regulatory decisions, briefings) that could move stock prices. Trading on this, even unintentionally, creates an appearance of corruption

"Enforce the laws we have" assumes the laws work. They don't. The STOCK Act's disclosure requirement is the current answer to "just disclose it," and it's been a joke in practice. Late filings are routine, the fines are often just $200, and disclosure only tells you what happened after the trade already occurred. Disclosure catches insider trading the way a security camera catches a burglar — after the house is empty. A ban prevents the act; disclosure just documents it for a news story six months later. The driving analogy inverts the actual asymmetry. Texting drivers can't see other drivers' texts. Officials trading stocks routinely have access to information that moves markets — pending legislation, classified briefings, regulatory timing — that the person on the other side of their trade doesn't have. That's not a comparable risk profile to ordinary driving; it's closer to letting casino pit bosses bet on the tables they're supervising. The concern isn't hypothetical texting-while-driving risk, it's a structural information asymmetry built into the job itself. "Only a few members sit on relevant committees" undercuts itself. If the informational advantage really is narrow, a ban costs almost nothing — most members claim they don't trade on inside information anyway, so giving it up should be trivial. The louder the objection to a ban, the more it suggests trading is more valuable to more members than the "it's only a few bad actors" framing admits. Blind trusts are a red herring, not a real concern. A true blind trust (independently managed, holdings undisclosed even to the official) is precisely the transparency-preserving solution here — the public knows the structure is blind, even if they don't know the daily holdings, which is a trade worth making. The realistic alternative isn't "opaque assets we can't see" versus "transparent stock trades we can see" — it's officials being legally barred from acting on privileged information at all, versus the status quo where they can act on it and merely have to mention it in a filing later. "Performative purity" is doing a lot of work to avoid the actual data. Multiple studies (Georgetown, and separate academic work on congressional trading) have found members of Congress and their spouses outperforming market benchmarks over years — not by rounding errors, but by margins that are hard to explain as coincidence at scale. That's not vibes; that's the empirical basis for the policy. The steelman against a ban isn't dead, though — it still has good points worth weighing: talent recruitment effects are real, enforcement of any new rule (including a ban) still requires political will that's currently lacking, and "blanket ban" proposals do vary a lot in whether they cover spouses, dependents, judiciary, etc. — scope questions the disclosure-only side is right to flag as unresolved.

Scale and specificity separate stock trading from home ownership. A house is one asset, tied to one policy area (local zoning), disclosed by public record, and nearly impossible to trade in and out of on a timeline that matches a tip. A portfolio of individual stocks can span dozens of companies across every sector Congress regulates, and can be bought or sold within hours of a closed briefing. "Congress members shouldn't own houses" doesn't scale the same way "Congress members shouldn't day-trade defense stocks the week before a committee vote on defense spending" does — the frequency, breadth, and timing-sensitivity are wildly different. A rule doesn't have to apply to every asset with any informational angle to be sound; it has to apply where the informational advantage is broad, fast-moving, and easily concealed. Stocks meet that bar in a way homes don't. Doctors and journalists aren't a real comparison — they don't write the rules for the industries they'd be trading in. A member of Congress isn't just "someone with inside info" the way a doctor is — they're the person voting on the regulation, budget, or contract that moves the stock. The conflict isn't "this person happens to know something," it's "this person is both player and referee." Corporate execs actually make the point for the ban: many are already barred from trading their own company's stock around material events, precisely because insider-adjacent trading by decision-makers is treated as a real problem worth restricting, not theater. "We already have insider trading laws" is the weakest plank here. Insider trading law requires proving an official traded on specific material nonpublic information — a brutally high bar that's led to approximately zero successful prosecutions of a sitting member of Congress despite years of well-documented suspicious trading patterns. If the enforcement mechanism has functionally never worked, pointing back to it isn't a counter-argument, it's proof the current system doesn't function as the "targeted" solution it's being sold as. "Treats every official like a crook" also describes... most conflict-of-interest law. Judges recuse from cases involving parties they have financial ties to — not because judges are presumed corrupt, but because the system doesn't rely on trusting individual judgment when the incentive structure is bad. A trading ban is the same logic: not a moral accusation, a structural fix that doesn't need to identify a criminal to be worth having. Where this argument still lands a real punch: it's right that recusal and blind trusts are the actual mechanism doing the work even under a ban — a ban is really just "mandatory blind trust or divest," not some novel purity test. And it's fair to press on why zoning-adjacent property or industry-specific expertise (a doctor voting on healthcare policy) don't get the same scrutiny — that inconsistency is a legitimate gap in most ban proposals, not fully answered by "stocks are just different in degree."